EARNINGS & TRADING: Nexus Infrastructure first-half loss narrows
The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
| Price | 0.20p on 07-08-2026 at 18:15:10 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.21p |
| Sell | 0.19p |
| Last Trade: | Sell 2,747.00 at 0.192p |
| Day's Volume: | 439,960 |
| Last Close: | 0.20p |
| Open: | 0.20p |
| ISIN: | GB00BSVYN304 |
| Day's Range | 0.20p - 0.20p |
| 52wk Range: | 0.18p - 0.265p |
| Market Capitalisation: | £4.30m |
| VWAP: | 0.200392p |
| Shares in Issue: | 2.15b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Theracryf PLC (TCF) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 2,747 | 0.192p | Ordinary |
15:59:05 - 07-Aug-26 |
| Buy* | 76,542 | 0.2025p | Ordinary |
15:50:32 - 07-Aug-26 |
| Buy* | 5,882 | 0.204p | Ordinary |
15:00:10 - 07-Aug-26 |
| Sell* | 32,172 | 0.192p | Ordinary |
11:39:34 - 07-Aug-26 |
| Sell* | 57,727 | 0.192p | Ordinary |
11:00:11 - 07-Aug-26 |
| Buy* | 260,000 | 0.2025p | Ordinary |
10:44:16 - 07-Aug-26 |
| Buy* | 204 | 0.21p | Ordinary |
09:31:29 - 07-Aug-26 |
| Buy* | 2,379 | 0.21p | Ordinary |
08:26:56 - 07-Aug-26 |
| Buy* | 125 | 0.21p | SI Trade |
08:26:56 - 07-Aug-26 |
| Buy* | 1,182 | 0.21p | SI Trade |
08:26:56 - 07-Aug-26 |
Theracryf PLC (TCF) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 24th Jun 2026 4:34 pm | RNS | Holding(s) in Company |
| 26th May 2026 2:40 pm | RNS | Holding(s) in Company |
| 15th May 2026 12:43 pm | RNS | Holding(s) in Company |
| 15th May 2026 7:00 am | RNS | Holding(s) in Company |
| 14th May 2026 7:00 am | RNS | Positive Ox-1 tox data in addiction programme |
| 21st Apr 2026 7:00 am | RNS-R | Investor Webinar |
| 20th Apr 2026 7:00 am | RNS | Successful GMP Manufacture Advances Ox-1 to Clinic |
| 16th Apr 2026 7:00 am | RNS | New Manufacturing Process Patent for Ox-1 |
| 14th Apr 2026 7:00 am | RNS | Non-Binding Proposal to Acquire TheraCryf’s Assets |
| 23rd Mar 2026 7:00 am | RNS | Ox-1 Programme Advances to Final Toxicology Study |